SMTL ID : 7om5.1

Anti-EGFR nanobody EgB4

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.48 Å

Oligo State

homo-dimer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 6 residues within 4Å: Chain A: A.14, G.15, S.84, L.85, K.86, H.123 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:G.15, A:L.85, A:K.86, A:H.123

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 3 residues within 4Å: Chain A: D.98, D.108, D.110 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:D.98, A:D.98, A:D.110 ZN.3: 3 residues within 4Å: Chain B: D.98, D.108, D.110 3 PLIP interactions: 3 interactions with chain B Metal complexes: B:D.98, B:D.98, B:D.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zeronian, M.R. et al., Structural insights into the non-inhibitory mechanism of the anti-EGFR EgB4 nanobody. Bmc Mol Cell Biol (2022)

Release Date

2022-03-02

Peptides

Nanobody EgB4: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Nanobody EgB4

Related Entries With Identical Sequence